Further in vitro and in vivo, experimental results have demonstrated that the knockdown of SLC16A1 effectively inhibits the growth of CCA cells, affirming its significant role as an oncogene in this type of cancer. The gene discussed is SLC16A1; the disease is cholangiocarcinoma.